RAC

2.92%

$1.94 race oncology ltd

General Comments / Chat, page-10152

First 10152 Last

Share
Profile

Follow
IndexInvestor

8,405 Posts.

1383

21/01/24

10:09

Post #: 71983741
Share

Originally posted by Rhino1963: ↑

ALL IMO

I have to disagree.
The Board is not obliged to accept any offer they deem below value.

I would expect the Board to advise Shareholders a comparison between the offer and what they deem as full value for the asset. The Triangle report is a good place to start.

Secondly, the fact that an offer is received indicates that it it not only the RAC Board and SHs that believe in the future value of the asset. It will trigger other interested parties and soph investors to take another look. i.e. it will shift the perception of Bisantrene being an old outdated chemo drug, to a tried and tested and previously approved drug with a massive potential to treat circa 20% of all cancers and more importantly protect the hearts of 100% of all cancer patients. Imagine that? Bisantrene is given to every cancer patient for cardio protection! Given imminent patent expiries, I would think other BPs could not ignore the situation.

I just finished reading "For Blood and Money" and it seems highly unlikely for a takeover by big pharma as they will want to see the asset further de-risked before stepping in.

An opportunistic VC backed enterprise might try, but their risk is not retaining the existing staff who have all the IP and experience in Bisantrene. It will likely set the program back a year or so. If they kept the same team what is the benefit to existing SHs? We would leave money on the table. Yes, they might bring some extra funds, which it seems is not an issue if the Board decided to raise more? Look at all the punters wanting the unexercised bonus options....

Our SOI and how tightly held register makes a hostile takeover difficult. It was recently reported that the Lambo club (100k plus) has increased their overall percentage ownership. It appears the Lambo's conviction in the asset and the team to realise the asset has only strengthened.

Cheers

Expand

Any corporate lawyers out there in HC cyberspace?
I'm not a corporate lawyer, or any kind of lawyer.

My understanding is that if an independent expert (usually a merchant bank) finds that a hostile offer is "unfair but reasonable", any Board of any company is OBLIGED to recommended acceptance in the absence of a superior offer and that If they don't do that they become personally liable for any losses suffered by non-acceptors, e.g. if the bid is later withdrawn.

Happy to be corrected.

RAC Price at posting: 81.0¢ Sentiment: Hold Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

SKS

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Bitcoin investors need to know the risks

NIM

Nimy to raise $1.21M to explore 'newsy' WA targets

ASX hits all time high out the gate on Friday trades following bullish US inflation data

MDI

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

AII

Almonty locks in govt agreement for tungsten oxide plant in South Korea

BHP

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

IMM

Immutep reports strong response rate from immunotherapies treating carcinomas

There are more pages in this discussion • 964 more messages in this thread...

First 10152 Last

Add RAC (ASX) to my watchlist

(20min delay)
Last $1.94		Change 0.055(2.92%)		Mkt cap ! $330.4M

Open	High	Low	Value	Volume
$1.89	$1.96	$1.85	$333.0K	174.5K

Buyers (Bids)

No.	Vol.	Price($)
1	3105	$1.94

Sellers (Offers)

Price($)	Vol.	No.
$1.95	7574	1

View Market Depth

No.	Vol.	Price($)
1	3105	1.940
2	30000	1.900
1	4861	1.880
1	3000	1.850
1	30000	1.840

Price($)	Vol.	No.
1.950	7574	1
1.995	10037	1
2.000	8000	3
2.020	4000	1
2.040	2000	1

Last trade - 16.10pm 12/07/2024 (20 minute delay)

RAC (ASX) Chart

General Comments / Chat, page-10152

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Bitcoin investors need to know the risks

Nimy to raise $1.21M to explore 'newsy' WA targets

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Almonty locks in govt agreement for tungsten oxide plant in South Korea

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Immutep reports strong response rate from immunotherapies treating carcinomas

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

General Comments / Chat, page-10152

Top Stories

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Bitcoin investors need to know the risks

Nimy to raise $1.21M to explore 'newsy' WA targets

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Almonty locks in govt agreement for tungsten oxide plant in South Korea

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Immutep reports strong response rate from immunotherapies treating carcinomas

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News